EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil

This publication has 27 references indexed in Scilit:

• Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib
  Clinical Cancer Research, 2006
• Phase I Study of Gefitinib Plus Celecoxib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
  Journal of Clinical Oncology, 2005
• Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2005
• Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study
  Laboratory Investigation, 2005
• Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): A natural disease model provides insights into viral carcinogenesis
  European Journal Of Cancer, 2005
• Retrospective Analysis of the Treatment Results for Patients with Squamous Cell Carcinoma of Tonsil
  Cancer Research and Treatment, 2005
• Matched-Pair Analysis of Survival of Never Smokers and Ever Smokers With Squamous Cell Carcinoma of the Head and Neck
  Journal of Clinical Oncology, 2004
• Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients
  International Journal of Cancer, 2004
• Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method
  Cancer, 2003
• Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and Neck
  New England Journal of Medicine, 2001